• Consider IREN for AI-compute exposure after its roughly 7% sell-off; the host favors it over NBIS on relative valuation, though management and share-performance concerns remain.
• NBIS may also offer an entry after the decline, but its premium to IREN looks steep; the thesis depends on continued GPU demand and deploying its capacity.
• HIMS is worth watching after its roughly 5% drop, with its GLP-1 business and potential peptide sales as catalysts; peptide timing depends on approvals, and the venture-investment upside is uncertain.
• Approach MSTR cautiously: it fell about 8% with Bitcoin, and the host’s stated plan was to wait for broader markets and yields to improve.

Nebius (NBIS)

• The host views Nebius as a higher-quality AI-compute company than IREN, citing its management and venture investment in ClickHouse.
• NBIS fell about 7% alongside other AI-related stocks. The host argued that the sell-off over OpenAI’s reported revenue was overdone, noting the company also forecast a strong fourth quarter.
• The host cited an EV/GP/RG valuation figure of 0.14 for Nebius and questioned whether it deserved a nearly 60% premium to IREN. They suggested a premium closer to 20% might be warranted. The transcript does not define this valuation measure.
• The investment thesis is that demand for GPU computing will persist even if OpenAI’s growth disappoints, as other customers—including Meta or Anthropic—could use available capacity.

Takeaways

• The host sees Nebius as a potentially attractive way to gain exposure to AI infrastructure after the sell-off, while acknowledging that its premium over IREN may be too large.
• The thesis depends on continued demand for GPU capacity and the company’s ability to put its secured power and computing capacity to use.

IREN (IREN)

• The host considers IREN the cheaper of the two AI-compute stocks discussed, citing an EV/GP/RG figure of 0.09, compared with 0.14 for Nebius. The transcript does not define this valuation measure.
• IREN fell about 7% with Nebius. The host argued that the market was treating them as a basket of AI stocks despite, in their view, both companies’ strong operating momentum.
• The host prefers IREN at current relative valuations, while acknowledging criticism of the company’s CEO and investor concerns tied to its share-price performance.

Takeaways

• The host favors IREN over Nebius on relative valuation, but investors would need to weigh the lower valuation against the concerns about management and share performance mentioned in the discussion.
• The broader thesis is that demand for AI computing could benefit IREN even if one major customer, such as OpenAI, spends less than expected.

Hims & Hers Health (HIMS)

• HIMS fell about 5% in the broad sell-off. The host argued that the stock was being treated like a speculative technology company despite what they described as strong cash flow and SaaS-like economics.
• The host highlighted HIMS’s $149-per-month GLP-1 prescription offering, arguing that it remains relatively inexpensive compared with historical prices and that patients may continue treatment long term.
• The host cited a study suggesting GLP-1 drugs could increase life expectancy, presenting this as evidence of a potentially expanding market. This was the host’s characterization of the study, not an independently assessed finding.
• HIMS has invested in Grail, whose investment value the host said had risen 178% in six months, and recently invested in Arboretum, a molecular-information startup. The host sees these as part of an emerging venture-investment arm, but future returns are uncertain.
• The host also pointed to potential peptide sales as a possible catalyst, saying approvals were expected soon and that HIMS has access to a CS Bio manufacturing facility.

Takeaways

• The host sees HIMS as a possible opportunity after its decline, based on its prescription business, cash flow, and potential growth in GLP-1s and peptides.
• Peptide sales were described as an upcoming catalyst, so the timing and impact depend on the approvals and sales actually proceeding.
• The venture investments could add value, but the host’s discussion of possible future gains from Arboretum was speculative.

Bitcoin (BTC)

• Bitcoin fell to around $81,000 during the risk-asset sell-off. The host described it as a hard asset that still sometimes trades in line with risk assets.
• The host welcomed a potential “breather” in Bitcoin’s advance, while saying they hoped the pause would continue.

Takeaways

• The discussion frames Bitcoin as exposed to short-term risk-off market moves, even though the host views it as a hard asset.
• The host did not give a price target or specific buying recommendation.

Strategy (MSTR)

• Strategy fell about 8% during the sell-off. The host said this was broadly consistent with the company’s sensitivity to Bitcoin’s price movements.
• The host described Strategy’s mNAV as roughly 1.2, saying this meant issuing shares through an at-the-market offering could still be technically accretive. They did not expect the company to do so at that point.
• The host’s stated strategy was to wait, with a recovery in yields and markets dependent in part on resolution of the Middle East situation.

Takeaways

• Strategy’s share performance is closely linked to Bitcoin and broader risk sentiment, so it may experience larger moves than Bitcoin itself.
• The host favored waiting rather than expecting an immediate share issuance or a quick recovery.

Strategy Preferred Instruments: “Stretch” and “SEDA”

• The host said “Stretch” had recovered and was trading near $99.49, while “SEDA” was near $99.42; they had previously fallen to about $98.80 after hours.
• The host speculated that investors might be selling SEDA to buy Stretch or Bitcoin, but said they could not identify a concrete reason for SEDA’s decline.
• The transcript does not provide clear ticker symbols for these instruments. It also compares their relative size, describing Stretch as roughly eight times larger than SEDA.

Takeaways

• The host sees the instruments’ prices moving differently and suggests investors may be reallocating between them or into Bitcoin.
• The proposed explanation is speculation; the host explicitly said they had not found a concrete cause for SEDA’s weakness.

AT&T (T) and Verizon (VZ)

• AT&T and Verizon rose during the risk-off session, which the host described as typical of more traditional, defensive stocks.
• The host also noted that both companies carry substantial debt and face significant disruption.

Takeaways

• The discussion illustrates how investors may rotate toward established companies during risk-off periods, but it also flags debt and industry disruption as concerns for these telecoms.

AI Infrastructure and Macro Themes

• The host linked the sell-off in AI-related stocks to concerns about OpenAI’s revenue, as well as a broader difficult macro environment.
• They argued that demand for GPU computing could remain strong even if OpenAI disappoints, with other potential customers—including Meta, Anthropic, and Claude—absorbing capacity.
• The discussion also cited rising oil and interest-rate concerns, including a 10-year Treasury yield moving from 5.35% to 5.24%. The host said the market remained unsettled and tied a possible recovery in yields to improving conditions in the Middle East.

Takeaways

• The host’s central AI thesis is that compute demand may be spread across multiple buyers rather than depending on OpenAI alone.
• The macro backdrop—especially rates, oil, and geopolitical developments—was presented as a continuing source of volatility for risk assets.